Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer
- PMID: 22882088
- PMCID: PMC3546388
- DOI: 10.1111/j.1365-2559.2012.04313.x
Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer
Abstract
Aims: The natural history of oral squamous cell carcinomas (OSCCs) is variable and difficult to predict. This study aimed to assess the value of the expression of poly(ADP-ribose) polymerase 1 (PARP-1), chromatin assembly factor-1 (CAF-1)/p60 and the stem cell markers CD133, CD166, CD44, CD44v6 and nestin as markers of outcome and progression-free survival in OSCC patients.
Methods: Clinical data were collected from 66 patients (41 male and 25 female, aged 29-92 years) who underwent surgery for OSCC of the tongue, floor, lips, and palate. During follow-up (range: 12-131 months), 14 patients experienced relapse/metastasis and/or death. The study was performed by immunohistochemistry on paraffin-embedded tumour tissues, western blot analysis of tumour protein lysates and human cell lines, and RNA silencing assays. In addition, the human papillomavirus (HPV) status of primary tumours was evaluated by immunohistochemistry and viral subtyping. Univariate and multivariate analyses were performed to determine the correlation between these parameters and the clinical and pathological variables of the study population.
Results and conclusions: We found that a PARP-1(high) /CAF-1 p60(high) /nestin(high) phenotype characterized the OSCCs with the worst prognosis (all HPV-negative). This may be of benefit in clinical management, since radio-enhancing anti-PARP-1 and/or anti-CAF-1/p60 agents may allow radioresistance to be bypassed in the nestin-overexpressing, metastasizing OSCC cells.
© 2012 Blackwell Publishing Limited.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/3546388/fef7eec8211f/his0061-1089-f1.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/3546388/464e4692a999/his0061-1089-f2.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/3546388/7c37d00ef880/his0061-1089-f3.gif)
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/3546388/ac4ae30c8dc0/his0061-1089-f4.gif)
Similar articles
-
FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?Int J Mol Sci. 2017 Feb 18;18(2):443. doi: 10.3390/ijms18020443. Int J Mol Sci. 2017. PMID: 28218707 Free PMC article.
-
Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides.Virchows Arch. 2021 May;478(5):961-968. doi: 10.1007/s00428-020-02952-z. Epub 2020 Oct 24. Virchows Arch. 2021. PMID: 33098490 Free PMC article.
-
Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker.Int J Mol Sci. 2012;13(9):11044-11062. doi: 10.3390/ijms130911044. Epub 2012 Sep 5. Int J Mol Sci. 2012. PMID: 23109837 Free PMC article.
-
Prognostic significance of neural stem cell markers, Nestin and Musashi-1, in oral squamous cell carcinoma: expression pattern of Nestin in the precancerous stages of oral squamous epithelium.Clin Oral Investig. 2015 Jul;19(6):1251-60. doi: 10.1007/s00784-014-1341-z. Epub 2014 Oct 29. Clin Oral Investig. 2015. PMID: 25352468
-
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.Clin Cancer Res. 2008 Jul 1;14(13):4085-95. doi: 10.1158/1078-0432.CCR-07-4404. Clin Cancer Res. 2008. PMID: 18593985
Cited by
-
Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.Cancers (Basel). 2023 Nov 27;15(23):5600. doi: 10.3390/cancers15235600. Cancers (Basel). 2023. PMID: 38067304 Free PMC article. Review.
-
Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.Strahlenther Onkol. 2021 Mar;197(3):231-245. doi: 10.1007/s00066-020-01653-5. Epub 2020 Jun 25. Strahlenther Onkol. 2021. PMID: 32588101 Free PMC article.
-
PARP and PARG inhibitors in cancer treatment.Genes Dev. 2020 Mar 1;34(5-6):360-394. doi: 10.1101/gad.334516.119. Epub 2020 Feb 6. Genes Dev. 2020. PMID: 32029455 Free PMC article. Review.
-
FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?Int J Mol Sci. 2017 Feb 18;18(2):443. doi: 10.3390/ijms18020443. Int J Mol Sci. 2017. PMID: 28218707 Free PMC article.
-
The Prognostic Values of PARP-1 Expression in Uveal Melanoma.Cells. 2021 Jan 31;10(2):285. doi: 10.3390/cells10020285. Cells. 2021. PMID: 33572586 Free PMC article.
References
-
- Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J. Clin. 2010;60:277–300. - PubMed
-
- Schuller DE, Wilson HE, Smith RE, Batley F, James AD. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx. Cancer. 1983;51:15–19. - PubMed
-
- Al-Sarraf M. Chemotherapy strategies in squamous cell carcinoma of the head and neck. Crit. Rev. Oncol. Hematol. 1983;1:323–355. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous